Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Strides Pharma Science Ltd

STAR.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Small Cap Analyst: BUY

Last Close

$10.14

▼ -2.16%

Market Cap $934.67M · Vol 168.37K

Key Metrics

P/E Ratio

14.54

FWD: 12.16

Market Cap

$934.67M

Small Cap

Div Yield

0.52%

Annual dividend

EPS Growth

+6.47%

YoY

RSI (14)

32.82

Momentum

Beta

0.98

vs Market

52W High

$12.90

21.22% below

52W Low

$8.05

21.08% above

Volume

168.37K

Avg 237.16K

P/B

2.78

Price-to-book

ROE

21.16%

Return on equity

Free Float

68.12%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Strides Pharma Science Ltd (STAR.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does STAR.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-3.59%

-9.64%

-16.24%

+12.84%

YTD

+7.49%

+8.12%

+334.48%

+233.91%

Financials & Valuation

TTM · Annual

Total Revenue	$519.88M
Net Income	$61.47M
Revenue Growth (YoY)	+13.01%
Gross Margin	51.11%
Operating Margin	13.35%
Net Profit Margin	11.82%
ROE	21.16%
ROA · ROIC	10.31% · 14.62%

P/E Ratio	14.54
Forward P/E (FY1)	12.16
PEG Ratio	0.42
P/S	1.78
P/B	2.78
P/FCF	71.30
EPS Growth	+6.47%
Outstanding Shares	92.17M

Technical Indicators

50-Day SMA	$11.06
200-Day SMA	$10.19
RSI (14)	32.82
Beta	0.98
52-Week High	$12.90
52-Week Low	$8.05

Volume Today	168.37K
Avg Daily Volume (30D)	237.16K
Relative Volume	0.71x
Volatility (10D)	26.53
Volatility (30D)	27.08
Free Float	68.12%

Analyst Consensus

BUY

Current Price $10.14

Mean Target $14.63

52W Low$8.05 52W High$12.90

Current

Target

$8.05 $12.90

Current Analyst target

+44.32% upside potential · 1 analysts

Identifiers

ExchangeNSE India

FIGIBBG001SDKDS7

ISININE939A01011

CountryIndia

Sub-IndustryGeneric Pharmaceuticals

Earnings DateOct 29, 2026

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

SUNPHARMA.NS Sun Pharmaceutical Industries Ltd -0.10% 4578.T Otsuka Holdings Co Ltd -3.26% CIPLA.NS Cipla Ltd -0.60% ZYDUSLIFE.NS Zydus Lifesciences Ltd -2.75% RICHTER.BU Richter Gedeon Vegyeszeti Gyar Nyrt +1.56%

Company Profile

Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.